Table 4.
Variables | MİLD (n = 66) | SEVERE (n = 533) | CRİTİCAL (n = 59) | P Value |
---|---|---|---|---|
Age, years | 53.5 ± 14.2 | 56.1 ± 13.7 | 63.6 ± 10 | <0.001 |
Gender, female, n | 33 (50%) | 223 (41%) | 30 (50%) | 0.152 |
Diabetes Mellitus, n | 12 (16%) | 91 (17%) | 16 (27%) | 0.155 |
Hypertension, n | 14 (21%) | 163 (30%) | 33 (55%) | <0.001 |
Vascular disease, n | 2 (3%) | 83 (15%) | 12 (20%) | 0.029 |
Heart Failure, n | 1 (1%) | 30 (5%) | 18 (30%) | <0.001 |
Valvuler Heart Disease, n | 0 | 15 (2.8%) | 4 (%4) | 0.076 |
COPD /Asthma, n | 2 (3%) | 95 (17%) | 14 (23%) | 0.003 |
CHA2DS2-VASc | 1.34 ± 0.7 | 1.57 ± 0.96 | 2.42 ± 1.03 | <0.001 |
CURB-65 | 0.64 ± 0.41 | 0.78 ± 0.38 | 1.27 ± 0.61 | <0.001 |
Hospital Stay, days | 5.1 ± 1.3 | 8.9 ± 2.1 | 14.5 ± 1.2 | <0.001 |
Laboratory findings | ||||
CRP, mg/L | 29 ± 13.4 | 40.9 ± 11.8 | 57.2 ± 12.3 | <0.001 |
WBC, x103/ μL | 8.45 ± 4.2 | 8.66 ± 4.21 | 9.48 ± 4.56 | <0.001 |
ESR | 21.9 ± 3.4 | 28.3 ± 1.3 | 33.2 ± 5.6 | 0.189 |
Radiographic Findings | ||||
Bilateral Ground Glass, n | 4 (6%) | 388 (72.7) | 5 (8.4%) | <0.001 |
Diffuse lung infiltration, n | 0 | 62 (11.6%) | 54 (91.5%) | <0.001 |
ECG Finding | ||||
Heart rate (beat/min) | 76.6 ± 13 | 77.6 ± 16.4 | 104.4 ± 12.7 | <0.001 |
PR, ms | 148.2 ± 5.14 | 157.4 ± 18.6 | 154.3 ± 7.42 | 0.314 |
QTc interval (ms) | 410.6 ± 18.3 | 415.1 ± 22.9 | 419.8 ± 22.5 | 0.091 |
QRS duration (ms) | 85.2 ± 9.6 | 86.27 ± 12.4 | 87.08 ± 16.01 | 0.722 |
CURB-65: Confusion, Urea, Respiratory rate, Blood pressure, age > 65 years.
CHA2DS2-VASc: Congestive heart failure/left ventricular dysfunction, Hypertension, Age (≥ 75 years 2 points), Diabetes. Stroke/transient ischemic attack (2 points), Vascular disease, Sex category.
CRP: Creactive protein, WBC: White Blood Cell count, ESR: Eritrocyte Sedimentation Rate.